Cost-effective strategies of testing for HIV and sexually transmitted infections (STIs)
Abstract
- Rates of chlamydia, gonorrhea, and infectious syphilis have risen in Canada from 2015 to 2019. An observed decrease in HIV cases has been detected recently, however a reduction in testing services throughout the COVID-19 pandemic may have impacted screening.
- Cost-effective strategies for providing access to HIV/STI testing include self-testing at home, testing at sex venues, in emergency and non-emergency health care settings, in pharmacies, and using partner notification services. Evidence of cost-effectiveness was also found in strategies targeted to people experiencing homelessness or residing in detention centres.
- Providing accessible, cost-effective HIV/STI testing has potential to reach individuals who have never received such screening before. Cost-effective HIV/STI screening can also provide financial benefits (i.e. reduced operational costs) to programs and facilities offering the services, such as hospitals and clinics.
Authors
The Ontario HIV Treatment Network: Rapid Response Service
Year
2022
Topics
- Epidemiology and Determinants of Health
- Determinants of Health
- Determinants of Health
- Health services
- Population(s)
- General HIV- population
- Testing
- Testing
- Co-infections
- Chlamydia
- Gonorrhea
- Syphilis
- Other
- Health Systems
- Financial arrangements
